These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8422287)

  • 21. High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.
    Milazzo G; Yip CC; Maddux BA; Vigneri R; Goldfine ID
    J Clin Invest; 1992 Mar; 89(3):899-908. PubMed ID: 1311720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells.
    Yee D; Jackson JG; Kozelsky TW; Figueroa JA
    Cell Growth Differ; 1994 Jan; 5(1):73-7. PubMed ID: 7510125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
    Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
    J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suramin inhibits growth and transforming growth factor-beta 1 (TGF-beta 1) binding in osteosarcoma cell lines.
    Kloen P; Jennings CL; Gebhardt MC; Springfield DS; Mankin HJ
    Eur J Cancer; 1994; 30A(5):678-82. PubMed ID: 8080687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells.
    Kawamura I; Lacey E; Mizota T; Tsujimoto S; Nishigaki F; Manda T; Shimomura K
    Anticancer Res; 1994; 14(2A):427-31. PubMed ID: 8017842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).
    Lu Y; Zi X; Zhao Y; Mascarenhas D; Pollak M
    J Natl Cancer Inst; 2001 Dec; 93(24):1852-7. PubMed ID: 11752009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures.
    Gansler T; Vaghmar N; Olson JJ; Graham SD
    J Urol; 1992 Sep; 148(3):910-4. PubMed ID: 1512858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
    McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
    J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
    J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.
    Rozen F; Pollak M
    Int J Oncol; 1999 Sep; 15(3):589-94. PubMed ID: 10427145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution.
    Kim JH; Sherwood ER; Sutkowski DM; Lee C; Kozlowski JM
    J Urol; 1991 Jul; 146(1):171-6. PubMed ID: 2056586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines.
    Favoni RE; de Cupis A; Ravera F; Cantoni C; Pirani P; Ardizzoni A; Noonan D; Biassoni R
    Int J Cancer; 1994 Mar; 56(6):858-66. PubMed ID: 7509779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
    Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
    Pommier GJ; Garrouste FL; el Atiq F; Roccabianca M; Marvaldi JL; Remacle-Bonnet MM
    Cancer Res; 1992 Jun; 52(11):3182-8. PubMed ID: 1375536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of suramin on cell proliferation of various types of human malignant cells].
    Bai LY; Miyazaki M; Namba M
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):387-91. PubMed ID: 1848419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
    Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ
    Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor-I receptors in human glial tumors.
    Merrill MJ; Edwards NA
    J Clin Endocrinol Metab; 1990 Jul; 71(1):199-209. PubMed ID: 2164527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.